• Patient-Derived Gastric Cancer Assembloids: Modeling Tumor-S

  2026-06-09

  This study introduces a novel gastric cancer assembloid model that integrates matched patient-derived tumor organoids with autologous stromal cell subpopulations. By closely recapitulating the cellular heterogeneity and microenvironmental complexity of primary tumors, the model enables more physiologically relevant drug screening and advances understanding of resistance mechanisms.

• Wnt-C59: Precision PORCN Inhibitor Workflows in Cancer Biolo

  2026-06-09

  Wnt-C59 enables selective, nanomolar-level control of Wnt secretion, making it indispensable for dissecting Wnt-driven cancer mechanisms and apoptosis induction. This guide translates recent research breakthroughs into actionable protocols and troubleshooting strategies, bridging Wnt pathway inhibition with regenerative and cancer biology.

• Spermine Tetrahydrochloride: Benchmarks in Protein & NMDA As

  2026-06-08

  Spermine tetrahydrochloride is a water-soluble polyamine crucial for stabilizing biological membranes and enhancing protein crystallization. Its well-characterized action in NMDA receptor signaling and protoplast protection underpins its versatility in neurobiology and structural biology workflows.

• Spiroplasma eriocheiris Entry in Drosophila S2 Cells: Cytosk

  2026-06-08

  The reference study reveals that Spiroplasma eriocheiris invades Drosophila S2 cells primarily via clathrin-mediated endocytosis and macropinocytosis, with infection strictly reliant on actin and microtubule integrity. These mechanistic insights clarify how S. eriocheiris exploits invertebrate host cell cytoskeletal pathways, offering a robust platform for future research into pathogen-host interactions and targeted cytoskeletal modulation.

• Lycopene Mitigates DON-Induced Intestinal Barrier Damage via

  2026-06-07

  This study demonstrates that lycopene effectively protects intestinal epithelial cells from deoxynivalenol (DON)-induced barrier dysfunction and inflammation by targeting the ERK pathway. The findings provide mechanistic insights into the therapeutic potential of lycopene against mycotoxin-related intestinal injury, with implications for translational research in gut barrier integrity.

• Ac-YVAD-CMK: Unlocking Caspase-1 Inhibition for Inflammation

  2026-06-06

  Discover how Ac-YVAD-CMK, a selective caspase-1 inhibitor, enables precise dissection of inflammatory mechanisms in liver immunology and beyond. This article reveals unique insights from recent TMEM16F research and advanced assay design strategies.

• ETS1 Modulates Mitophagy via SENP2/HSPA8/FUNDC1 in BPD Model

  2026-06-05

  This study uncovers the regulatory role of ETS1 in mitigating bronchopulmonary dysplasia (BPD) by inhibiting mitochondrial damage-induced mitophagy through the SENP2/HSPA8/FUNDC1 axis. These mechanistic insights provide a foundation for targeted autophagy modulation in neonatal lung disease.

• BCECF-AM in Translational pH Sensing: A New Era for Cell Bio

  2026-06-05

  This article explores how BCECF-AM, a cell-permeable ratiometric fluorescent dye, is transforming intracellular pH measurement in plant, mammalian, and microbial systems. By integrating mechanistic insights with strategic guidance, we bridge advanced protocol design from 'Plant Protein Secretion: Methods and Protocols' with the practical deployment of BCECF-AM for high-impact translational research, highlighting opportunities and limitations in dynamic protein secretion studies.

• AO/PI Staining Solution: Precision Tools for Translational I

  2026-06-04

  Explore how dual fluorescent DNA dyes in AO/PI Staining Solution advance live/dead cell discrimination, enabling translational researchers to achieve greater mechanistic insight and workflow reliability—especially in disease modeling such as diabetic nephropathy.

• 6-Thioguanine Inhibits EV71 via BIRC3-Mediated Autophagy Sup

  2026-06-04

  This article examines new evidence that 6-thioguanine potently inhibits Enterovirus 71 (EV71) replication by attenuating BIRC3-mediated autophagy in vitro. These findings suggest a mechanistic rationale and experimental framework for repurposing this thiopurine immunosuppressant as an antiviral agent, with potential implications for hand, foot, and mouth disease (HFMD) therapy.

• Thiothixene: Typical Antipsychotic Agent Boosts Efferocytosi

  2026-06-03

  Thiothixene is redefining its utility beyond schizophrenia treatment, now empowering immunological research as a robust efferocytosis enhancer. Explore data-driven workflows, practical troubleshooting, and the latest insights on leveraging APExBIO's validated thiothixene for dual-function neuroimmune studies.

• Thiothixene: Typical Antipsychotic Agent for Efferocytosis A

  2026-06-03

  Thiothixene bridges psychiatry and immunology by uniquely enhancing macrophage efferocytosis through Stra6L and Arginase 1 induction, as well as antagonizing dopamine's effects. Learn how to implement, optimize, and troubleshoot thiothixene-driven efferocytosis workflows to accelerate research in cell clearance and psychotic disorder therapy.

• FITC Goat Anti-Rabbit IgG (H+L) Antibody in Advanced Immunod

  2026-06-02

  The FITC Goat Anti-Rabbit IgG (H+L) Antibody transforms immunofluorescence and flow cytometry by delivering exceptional signal amplification and specificity. Discover its robust performance in translational research workflows, practical protocol optimizations, and troubleshooting strategies that ensure reproducible results even in complex biomarker studies.

• COG133 Peptide Modulates miR-146a and Inflammation in Diabet

  2026-06-02

  This study demonstrates that the ApoE-mimetic peptide COG133 promotes fibroblast migration, upregulates miR-146a, and reduces pro-inflammatory signaling in human diabetic dermal fibroblasts. The findings highlight COG133's dual role in supporting wound healing and exhibiting antibacterial effects, revealing new opportunities for targeted intervention in diabetic ulcer management.

• Linarin Induces Cell Cycle Arrest in NSCLC via Cyclin A2 Dow

  2026-06-01

  This study identifies Linarin, a Herba Patriniae component, as a potent inhibitor of non-small-cell lung cancer (NSCLC) cell proliferation by inducing G0/G1 cell cycle arrest and senescence, largely through downregulation of Cyclin A2 and related targets. The findings highlight Linarin's therapeutic promise and underscore the value of advanced S-phase DNA synthesis assays in mechanistic cancer research.

16121 records 1/1075 page Next 12345 下5页 Last page